Roll Call published a commentary today by Nancy Davenport-Ennis of the National Patient Advocate Foundation on the effects of the sequester on cancer care. The op ed states that these ‘cuts are shown to directly impact patients through higher copayments, longer travel times and increased travel expenses, visits to multiple providers and locations for care and services, and delays seeking treatment even as cancer progresses.’ Despite these facts, some have called for even deeper cuts to cancer care as a way to find savings. If the impact on patient care has been devastating and has not resulted in any real cost savings under sequestration, more patients will be turned away from lower cost community-based care if even deeper cuts are enacted. For more information on the impact of the sequester on cancer care, please visit the NPAF web site at www.npaf.org.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagsbusiness development biotech industry Intellectual Property health Plant biotechnology Food BIO Investor Forum BIO Health Care BIO EVENT BIOTECH Benefits of biotech crops patent global food crisis agriculture FDA biotechnology Biotechnology Industry Sustainability Animal biotechnology
- Most Popular
Latest VideoWhat's Hot & What's Not in Oncology (a web panel co-sponsored by BIO and ShareVault) View All >